ASN Kidney Week 2020
Kidney Week 2020 ...
Kidney Week 2020 ...
Kidney Week 2020 ...
Kidney Week 2020 ...
Kidney Week 2019 ...
Kidney Week 2020 ...
Kidney Week 2020 ...
The multinational, cross-sectional, noninterventional CAPTURE study was designed to examine the 2019 prevalence of ...
Patients with diabetes mellitus commonly develop micro- and macrovascular complications that include chronic kidney ...
Racial/ethnic minorities are 1.5 to 4 times more likely than others to develop end-stage renal disease (ESRD). Among ...
The preferred vascular access types for patients receiving maintenance hemodialysis are arteriovenous fistula (AVF) and ...
Data from three phase 3 trials of roxadustat were examined in recent subgroup analyses. Roxadustat is an oral ...
Hepatorenal syndrome type 1 (HRS-1) is a severe form of acute kidney injury experienced by people with cirrhosis. The ...
Researchers, led by Robert Provenzano, MD, recently conducted subgroup analyses of efficacy data from three pivotal ...
Patients with combined predialysis and postdialysis hypokalemia are at increased risk for mortality. Results of the ...
Patients with cirrhosis may develop hepatorenal syndrome type 1 (HRS-1), a severe but reversible acute kidney injury. ...
Patients with end-stage kidney disease receiving maintenance hemodialysis may be at increased of illness and death from ...
Researchers in Spain, led by David Vizcaya, PhD, conducted a longitudinal retrospective study among adult patients with ...
The prevalence of chronic kidney disease (CKD) is greater in individuals ≥65 years of age compared with those 45 to 64 ...
Patients undergoing percutaneous coronary intervention (PCI) are at risk for acute kidney injury (AKI). There are few ...
Researchers in Japan conducted study of roxadustat, an orally active hypoxia-inducible factor prolyl hydroxylase ...
The loss of physical function in patients with chronic kidney disease (CKD) is due, in part, to the development of ...
As the coronavirus disease 2019 (COVID-19) spread around the world, reports of renal involvement varied across regions. ...
Results of the TEMPO (Tolvaptan Efficacy and Safety in the Management of ADPKD and its Outcomes) and REPRISE ...
Patients with advanced chronic kidney disease (CKD) commonly develop metabolic acidosis, which may be associated with ...
Critically ill patients often develop acute kidney injury (AKI), a condition that has a broad spectrum of severity. ...
Early data on acute kidney injury (AKI) associated with coronavirus disease 2019 (COVID-19) suggested a high prevalence ...
Autosomal dominant polycystic kidney disease (ADPKD) is a hereditary systemic kidney disease characterized by ...
Amid safety concerns raised following trials of target hemoglobin, several jurisdictions have adopted a more ...
Patients with metabolic acidosis may develop wide-ranging complications consistent with the fact that many critical cell ...
An estimated 8% to 18% of hospitalized patients develop acute kidney injury (AKI). Hospitalized patients who develop AKI ...
Patients with hyperkalemia find managing the condition with a strict diet is difficult and limiting. Amy Larkin, PharmD, ...
Patients with coronavirus disease 2019 (COVID-19) may develop acute kidney disease (AKI). The United Kingdom National ...
In patients with acute kidney injury (AKI) requiring dialysis (AKI-D), the rate of adverse outcomes is high. There are ...
Metabolic acidosis is a risk factor for progression of chronic kidney disease (CKD). There are few data available on the ...
Advertisement
Advertisement
